Evidence map›Paper›PMID 40700016›Full record

ArticleCell reports2025

RNA-programmable cell-type monitoring and manipulation in the human cortex with CellREADR.

Elizabeth A Matthews, Jeffrey B Russ, Yongjun Qian, Shengli Zhao, Peyton Thompson, Muhib Methani, Matthew Vestal, Z Josh Huang, Derek Southwell

Erratum issuedAbstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Elizabeth A MatthewsDepartment of Neurosurgery, Duke University, Durham, NC, USA; Department of Neurobiology, Duke University, Durham, NC, USA.
Jeffrey B RussDepartment of Neurosurgery, Duke University, Durham, NC, USA; Department of Pediatrics, Duke University, Durham, NC, USA.
Yongjun QianDepartment of Neurobiology, Duke University, Durham, NC, USA.
Shengli ZhaoDepartment of Neurobiology, Duke University, Durham, NC, USA.
Peyton ThompsonDepartment of Neurosurgery, Duke University, Durham, NC, USA; Department of Neurobiology, Duke University, Durham, NC, USA.
Muhib MethaniDepartment of Neurosurgery, Duke University, Durham, NC, USA; Department of Neurobiology, Duke University, Durham, NC, USA.
Matthew VestalDepartment of Neurosurgery, Duke University, Durham, NC, USA.
Z Josh HuangDepartment of Neurobiology, Duke University, Durham, NC, USA; Biomedical Engineering, Duke University, Durham, NC, USA. Electronic address: josh.huang@duke.edu.
Derek SouthwellDepartment of Neurosurgery, Duke University, Durham, NC, USA; Department of Neurobiology, Duke University, Durham, NC, USA; Biomedical Engineering, Duke University, Durham, NC, USA. Electronic address: derek.southwell@duke.edu.

Funding

RNA-programmable cell-type targeting, editing, and therapyDP1MH129954 · NIMH · DUKE UNIVERSITY · PI HUANG, Z JOSH · 2021 to 2025
$5.6M
Exploring cortical inhibitory circuit design in the human brainDP2MH140149 · NIMH · DUKE UNIVERSITY · PI SOUTHWELL, DEREK G. · 2024 to 2024
$1.4M
Discovering the cell type basis of the IT projection system and its dysregulation after perinatal HIEK08NS133292 · NINDS · DUKE UNIVERSITY · PI Jeffrey B Russ · 2024 to 2026
$638k
NIMH NIH HHS DP1 MH129954NIMH NIH HHS DP2 MH140149NINDS NIH HHS K08 NS133292
6 · The paper itself

Abstract

Reliable and systematic access to diverse cell types is necessary for understanding the organization, function, and pathophysiology of human neural circuits. Methods for targeting human neural populations are scarce and currently center on identifying transcriptional enhancers and engineering viral capsids. Here, we demonstrate the utility of cell access through RNA sensing by endogenous adenosine deaminase acting on RNA (ADAR) (CellREADR), a programmable RNA sensor-effector technology that couples cellular RNA sensing to effector protein translation, for accessing, monitoring, and manipulating specific neuron types in the human cortex ex vivo. We design CellREADRs to target two subpopulations-calretinin (CALB2) GABAergic interneurons and forkhead box protein P2 (FOXP2) glutamatergic projection neurons-and then validate targeting specificity using histological, electrophysiological, and transcriptomic methods. CellREADR expression of channelrhodopsin and GCamp enables the manipulation and monitoring of these populations in live cortical microcircuits. By demonstrating specific, reliable, and programmable experimental access to human neuronal subpopulations, our results highlight CellREADR's potential for studying neural circuits and treating brain disorders.

Indexed as

Adenosine DeaminaseCerebral CortexRNAHumansInterneuronsMaleNeuronsAdenosine DeaminaseRNAcalcium imagingcellular accesscortexCP: Molecular biologyCP: Neuroscienceexcitatory neuronhuman neuroscienceinterneuronoptogeneticsorganotypic slice culturePatchSeqRNA sensor

Identifiers

PMID40700016
PMCPMC12414115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.